Andrew Pollack, who has covered the business and science of biotechnology for the New York Times since 2000, is leaving the paper via a buyout offer.
John Carroll of Fierce Biotech called him Pollack one of the industry’s top reporters and wrote, “Few top writers in this business are given the time to leisurely explore a topic the way Pollack has. And no one has better access to the people who are making a difference in biopharma.”
He joined The Times in 1981, covering computers and telecommunications, after three years at The Dallas Times-Herald.
He previously covered technology and other business while based in San Francisco from 1985 to 1992, Tokyo from 1992 to 1997 and Los Angeles from 1997 to 2000. He still works out of the Los Angeles bureau.
A native of Queens, New York, Pollack earned a bachelor’s degree from Princeton and a master’s degree in civil and environmental engineering from the Massachusetts Institute of Technology.
